Global Digital Genome Market | Growth, Trends, Analysis

1
The Global Digital Genome Market at CAGR of 9.57
by 2028
Triton Market Research presents the Global
Digital Genome Market segmented by Application
(Academic Research, Diagnostics, Agricultural,
Drug Discovery, Personalized Medicine, Other
Applications), Product (DNA/RNA Analysis,
Sequencing and Analysis Software, Sample Prep
Instruments, Sequencing and Analyzer Instruments,
Sequencing Chips), End-user (Academic Research
Institutes, Diagnostics and Forensic Labs,
Hospitals, Other End-users), and by Geography
(Middle East and Africa, Europe, Asia-Pacific,
Latin America, North America). It further
discusses the Market Summary, Industry Outlook,
Porter's Five Forces Model, Impact of COVID-19,
Market Attractiveness Index, Vendor Scorecard,
Key Insights, Drivers, Restraints, Opportunities,
Company Profile, Research Methodology Scope,
Global Market Size, Forecasts Analysis
(2021-2028).
GLOBAL DIGITAL GENOME MARKET 2021-2028 CAGrT9.57
The regional paradigm of DIGITAL GENOME MARKET
was dominated by NORTH AMERICA by capturing a
majority of revenue share. On the other hands,
ASIA-PACIFIC is anticipated to be the fastest
growing regional market over the forecast
period. www.tritonmarketresearch.com
Request a Free Sample https//www.tritonmarketres
earch.com/reports/digital-genome-marketrequest-fr
ee-sample Triton's research report intimates that
the global digital genome market is projected to
expand in terms of revenue by 9.57 of CAGR
during the evaluated phase of 2021-2028. A
digital genome is a detailed digital set of
genetic material found in a cell or an organism.
It primarily deals with genes and their
functions, assisting in detecting the cause of
chronic conditions. Factors such as technological
advancements and awareness in the developing
nations regarding DNA sequencing technologies are
generating several growth opportunities for the
studied market over the estimated period. For
instance, artificial intelligence and machine
learning technologies are adopted to overcome
several genomic issues, such as annotating
genomic sequence elements and discovering
2
splice sites. Such advancements are primarily
motivating the growth of the digital genome
market globally. However, the lack of skilled
professionals having knowledge of genome
technology, hampers the overall growth of the
studied market. North America holds the largest
market share in the digital genome market, and is
expected to continue its stronghold till 2028.
The region's growth can be attributed to the high
adoption of advanced techniques by the research
institutes in the United States. Moreover, the
increased investments in gene therapy
advancements, along with the high prevalence of
diseases, including Alzheimer's diseases, cancer,
and dementia, are driving the studied market's
growth. Above all, a surge in the conferences and
workshops relating to gene editing is expected to
augment the digital genome market's progression
across North America. The key companies profiled
in the digital genome market are Illumina Inc, F
Hoffmann-La Roche, Qiagen NV, Thermo Fisher
Scientific Inc, Pacific Bioscience, Regeneron
Pharmaceuticals, Biomerieux SA, Abbott
Laboratories, Oxford Nanopore Technologies Ltd,
Bio-Rad Laboratories Inc, Agilent Technologies
Inc, Perkinelmer Inc, Becton Dickinson and
Company (BD), and Inscripta. Several established
market players are upgrading their technology to
satisfy the requirements of their clientele,
which poses a threat for the new market players
to enter the market. Moreover, the entry barrier
is higher in the digital genome market as it
involves complicated technologies. Furthermore,
multinational companies are thriving to launch
numerous technologically advanced products to
attract more consumers to capture significant
market share. This indicates the competition
among the existing market players is likely to
remain relatively higher over the forecast period.
Contact Us
sales_at_tritonmarketresearch.com Phone 44 7441
911839